期刊文献+

CKIP-1、p-Akt在大肠癌组织中的表达及意义 被引量:6

Determination of CKIP-1 and p-Akt Expression in Colorectal Cancer and Their Significance
下载PDF
导出
摘要 目的研究CKIP-1与大肠癌的发生发展、预后的关系及与PI3K/Akt通路的相关性,为大肠癌及分子靶向治疗提供可能的靶点。方法收集大肠癌患者手术标本,通过免疫组化方法检测CKIP-1蛋白、p-Akt蛋白在大肠癌组织中的表达;分析CKIP-1的表达与大肠癌临床病理参数、p-Akt表达的相关性。结果 CKIP-1蛋白主要位于胞质及包膜上,部分位于胞核;CKIP-1蛋白在大肠癌组织中的阳性表达率显著低于癌旁正常组织;CKIP-1在腺瘤组织中的表达率显著低于癌旁正常组织。p-Akt阳性染色大部分定位于胞核;少部分也定位于胞质;p-Akt在大肠癌组织中的表达明显高于腺瘤组织,p-Akt在腺瘤组织中的表达明显高于癌旁正常组织,3者均具有显著性差异。CKIP-1的表达与大肠癌的分化程度显著相关,p-Akt的表达与大肠癌的分化程度、临床分期显著相关。在大肠癌中,CKIP-1蛋白的表达与p-Akt蛋白的表达呈负相关。结论 CKIP-1可能参与了大肠癌的发生发展,并可能通过下调PI3K/Akt介导的细胞信号转导通路发挥作用。 Objective To investigate the expression of CKIP - 1 and p - Akt protein in colorectal carcinoma and the correlation be- tween their expression and clinical pathological characteristics and prognosis, as well as the possible role of CKIP - 1 in PI3 K/Akt path- way. Methods CKIP - 1 and p - Akt protein expression was determined in 50 colorectal cancerous tissues and it's corresponding normal paracancerous tissues, as well as 31 colorectal adenoma tissues by immunohistoehemistry (IHC) research. Results CKIP - 1 protein was localized mainly in plasma and cell membrane, although faint staining was also observed in nuclear. The positive rate was 73% in cancer- ous tissues, which was significantly lower than paracancerous tissues( 1100% , P 〈 0.01 ). The positive rate of CKIP - 1 was 87. 1% in adenoma tissues(P 〈 0.05) ,which was significantly lower than paracancerous tissues, p -Akt protein immunoreaetivity was found mainly in the nuclear, and faint staining was also found in the plasma. The positvely rate was 80% in cancerous tissues, 58.1% in adenoma tis- sues, and 16% in paraeancerous tissues. Clinicopathological analysis revealed that CKIP -1 expression was significantly correlated with the degree of differentiation of colorectal cancer, and p- Akt expression was significantly correlated with the degree of differentiation and the TNM classification. The expression of CKIP - 1 was negatively correlated with the expression of p - Akt. Conclusion CKIP - 1 was involved in the development of colorectal cancer and may inhibit colorectal development throuth the inhibition of PI3 K/Akt pathway.
出处 《医学研究杂志》 2013年第2期63-67,共5页 Journal of Medical Research
关键词 CKIP-1 P-AKT 大肠癌 CKIP - 1 p - Akt Colorectal cancer
  • 相关文献

参考文献10

  • 1Zhang L,Tie Y,Tian C. CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM[J].Cellular Signalling,2006,(09):1386-1395. 被引量:1
  • 2Bosc DG,Graham KC,Saulnier RB. Identification and characterization of CKIP-1,a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2[J].Journal of Biological Chemistry,2000,(19):14295-14306. 被引量:1
  • 3Sheng H,Shao J,Townsend CM Jr. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells[J].Gut,2003,(10):1472-1478. 被引量:1
  • 4Hennessy BT,Smith DL,Ram PT. Exploiting the PI3K/Akt pathway for cancer drug discovery[J].Nature Reviews Drug Discovery,2005,(12):988-1004. 被引量:1
  • 5Tokuda E,Fujita N,Oh hara T. Casein kinase 2-interacting protein-1,a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo[J].Cancer Research,2007,(20):9666-9676. 被引量:1
  • 6Greene FL,Page DL,Fleming ID. AJCC cancer staging manual[M].New York:Springer-Verlag,2002. 被引量:1
  • 7Nanami I,Shuho S,Masafumi I. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma[J].Cancer,2002,(12):3127-3133. 被引量:1
  • 8王振军,黄莚庭.应进一步加强我国结肠癌的基础研究[J].中华医学杂志,2004,84(9):705-707. 被引量:22
  • 9Zhang L,Xing G,Tie Y. Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis[J].EMBO Journal,2005,(04):766-778. 被引量:1
  • 10Fresno Vara JA,Casado E,de Castro J. PI3K/Akt signalling pathway and cancer[J].Cancer Treatment Reviews,2004,(02):193-204. 被引量:1

二级参考文献16

  • 1Jemal A, Tiwari RC, Marray T, et al. Cancer statistics 2004 CA Cancer J Clin ,2004, 54:8-29. 被引量:1
  • 2Maroun J, Ng E, Berthelot JM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can, 2003,24:91-101. 被引量:1
  • 3Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell,1990,61:759-765. 被引量:1
  • 4Lynch HT, Smyrk TC, Watson P,et al. Genetics,natural history, tumour spectrum, and pathology of hereditary nonpolyposis colorectal cancer:an updated review. Gastroenterology,1993,104:1535-1549. 被引量:1
  • 5Ionov Y,Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 1993,363:558-561. 被引量:1
  • 6Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science, 1994,263:1625-1629. 被引量:1
  • 7Markowitz S, Wang J, Myeroff L, et al.Inactivation of the type TGF-β receptor in colon cancer cells with microsatellite instability. Science, 1995,268:1336-1337. 被引量:1
  • 8Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell line. Cancer Res, 1997,57:808-811. 被引量:1
  • 9Ahuja N, Mohan AL, Li Q, et al. Association between CpG island and microsatellite instability in colorectal cancer. Cancer Res, 1997,57:3370-3374. 被引量:1
  • 10Toyota M. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA,1999,96:8681-8686. 被引量:1

共引文献21

同被引文献114

  • 1张学东,王新杰.老年人大肠癌特点分析[J].中国临床医生杂志,2004,32(9):27-28. 被引量:1
  • 2高健群,易少波.P^(16)和P^(53)蛋白在大肠癌中的表达及其临床意义[J].中国医刊,2004,39(12):39-40. 被引量:2
  • 3陈伟,陈谦学,王军民,郭熙雄,吴立权.NF-κB和uPA在人脑胶质瘤中的表达[J].中国临床神经外科杂志,2007,12(2):83-85. 被引量:4
  • 4张珊文.抑癌基因p53治疗恶性肿瘤的基础与临床研究[J].武警医学,2007,18(4):245-248. 被引量:5
  • 5King AR, Lodola A, Carmi C, Fu J, Mor M, PiomeUi D. A critical cysteine residue in monoacylglycerol lipase is :rgeted by a new class of isothiazolinone- based enzyme inhibitors. Br J Pharmacol 2009; 157:974-983 [PMID: 19486005 DOI: 10.1111/ j.1476-5381.2009.00276.x]. 被引量:1
  • 6Blankman : Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. : Biol 2007; 14:1347-1356 [PMID: 18096503 DOI: 10.1016/ j.chembioL2007.11.006]. 被引量:1
  • 7Hermanson DJ, Marnett LJ. Cannabinoids, endocannabinoids, and cancer. Cancer Metastasis Rev 2011; 30:599-612 [PMID: 22038019 DOI: 10.1007/s10555-011-9318-8]. 被引量:1
  • 8Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001; 413:527-531 [PMID: 11586361 DOI: 10.1038/35097089]. 被引量:1
  • 9Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pav6n FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009; 5:37-44 [PMID: 19029917 DOI: 10.1038/ nchembio.129]. 被引量:1
  • 10Pisanti S, Picardi P, D'Alessandro A, Laezza C, Bifulco M. The endocannabinoid signaling system in cancer. Trends Pharmacol Sci 2013; 34" 273-282 [PMID: 23602129 DOI: 10.1016/j.tips.2013.03.003]. 被引量:1

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部